OSCR Oscar Health, Inc.
NYSE · SEC CIK 1568651 · EDGAR
- Bought, last 12 months
- $11.92M 1 purchases by 1 insiders
- Sold, last 12 months
- $150.02M 35 sales by 7 insiders
- Filings on record
- 268 since 2021-08-20, latest 2026-09-22 16:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Bertolini Mark T | CEO, Dir | $11.92M | $70.68M |
| Schlosser Mario | Dir | — | $68.79M |
| Blackley Richard Scott | CFO | — | $7.94M |
| Liang Janet | Pres, Oscar Insurance | — | $821.1K |
| WITTMAN VANESSA AMES | Dir | — | $806.0K |
| McAnaney Adam | CLO | — | $783.5K |
| Baltrus Victoria | CAO | — | $194.5K |
| Gassen William | Dir | — | — |
| Thrive Partners II GP, LLC | Dir, 10% | — | — |
| Plouffe David | Dir | — | — |
Transactions 330
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-07 | 2021-12-07 | OSCR | Blackley Richard Scott | CFO | S - Sale+OE | — | -86.2K | 168.8K | -34% | — |
| D | 2021-12-03 | 2021-12-01 | OSCR | Joyce Meghan V. | COO | M - OptEx | — | +7,015 | 41.7K | +20% | — |
| D | 2021-12-03 | 2021-12-02 | OSCR | Joyce Meghan V. | COO | S - Sale+OE | $8.75 | -3,090 | 38.6K | -7% | -$27.0K |
| D | 2021-12-03 | 2021-12-01 | OSCR | CFO | M - OptEx | — | +7,015 | 7,015 | New | — | |
| D | 2021-12-03 | 2021-12-02 | OSCR | CFO | S - Sale+OE | $8.81 | -2,090 | 4,925 | -30% | -$18.4K | |
| D | 2021-12-03 | 2021-12-02 | OSCR | Weaver Dennis | Chief Clinical Off | S - Sale+OE | $8.79 | -2,410 | 9,084 | -21% | -$21.2K |
| DM | 2021-12-03 | 2021-12-01 | OSCR | Weaver Dennis | Chief Clinical Off | M - OptEx | — | +6,171 | 9,490 | +186% | — |
| MAI | 2021-09-28 | 2021-09-09+ | OSCR | Thrive Partners VII GP, LLC | 10% | P - Purchase | $17.47 | +1.07M | 3.92M | +38% | +$18.73M |
| MAI | 2021-09-28 | 2021-09-09+ | OSCR | Kushner Joshua | Co-Founder, Vice COB, Dir, 10% | P - Purchase | $17.47 | +1.07M | 3.92M | +38% | +$18.73M |
| 2021-09-17 | 2021-09-16 | OSCR | Schlosser Mario | CEO, Dir | P - Purchase | $17.53 | +57.3K | 57.3K | +337,059% | +$1.00M | |
| MI | 2021-09-16 | 2021-09-14+ | OSCR | Kushner Joshua | Co-Founder, Vice COB, Dir, 10% | P - Purchase | $18.01 | +839.1K | 4.76M | +21% | +$15.11M |
| MI | 2021-09-16 | 2021-09-14+ | OSCR | Thrive Capital Partners VII Growth, L.P. | 10% | P - Purchase | $18.01 | +839.1K | 4.43M | +23% | +$15.11M |
| MI | 2021-09-13 | 2021-09-09+ | OSCR | Kushner Joshua | Co-Founder, Vice COB, Dir, 10% | P - Purchase | $17.41 | +1.07M | 3.54M | +43% | +$18.67M |
| MI | 2021-09-13 | 2021-09-09+ | OSCR | Thrive Partners VII Growth GP, LLC | 10% | P - Purchase | $17.41 | +1.07M | 3.69M | +41% | +$18.67M |
| MI | 2021-09-07 | 2021-09-02+ | OSCR | Thrive Capital Partners VII Growth, L.P. | 10% | P - Purchase | $18.07 | +485.5K | 2.69M | +22% | +$8.77M |
| MI | 2021-09-07 | 2021-09-02+ | OSCR | Kushner Joshua | Co-Founder, Vice COB, Dir, 10% | P - Purchase | $18.07 | +485.5K | 2.69M | +22% | +$8.77M |
| D | 2021-09-02 | 2021-09-01 | OSCR | Weaver Dennis | Chief Clinical Off | M - OptEx | — | +8,333 | 8,350 | +49,018% | — |
| D | 2021-09-02 | 2021-09-01 | OSCR | Weaver Dennis | Chief Clinical Off | S - Sale+OE | $17.21 | -3,027 | 5,323 | -36% | -$52.1K |
| D | 2021-09-02 | 2021-09-01 | OSCR | Joyce Meghan V. | COO | M - OptEx | — | +58.7K | 58.7K | +345,094% | — |
| D | 2021-09-02 | 2021-09-01 | OSCR | Joyce Meghan V. | COO | S - Sale+OE | $17.17 | -24.0K | 34.7K | -41% | -$412.3K |
| MI | 2021-09-01 | 2021-08-30+ | OSCR | Thrive Partners VII GP, LLC | 10% | P - Purchase | $15.00 | +635.4K | 2.05M | +45% | +$9.53M |
| MI | 2021-09-01 | 2021-08-30+ | OSCR | Kushner Joshua | Co-Founder, Vice COB, Dir, 10% | P - Purchase | $15.00 | +635.4K | 2.36M | +37% | +$9.53M |
| MI | 2021-08-27 | 2021-08-25+ | OSCR | Thrive Partners VII Growth GP, LLC | 10% | P - Purchase | $13.85 | +454.2K | 1.51M | +43% | +$6.29M |
| MI | 2021-08-27 | 2021-08-25+ | OSCR | Kushner Joshua | Co-Founder, Vice COB, Dir, 10% | P - Purchase | $13.85 | +454.2K | 1.72M | +36% | +$6.29M |
| MI | 2021-08-24 | 2021-08-20+ | OSCR | Kushner Joshua | Co-Founder, Vice COB, Dir, 10% | P - Purchase | $12.76 | +1.27M | 1.27M | New | +$16.19M |
| MI | 2021-08-24 | 2021-08-20+ | OSCR | Thrive Partners VII Growth GP, LLC | 10% | P - Purchase | $12.76 | +1.27M | 194.4K | New | +$16.18M |
| D | 2021-08-20 | 2021-08-18 | OSCR | Schlosser Mario | CEO, Dir | M - OptEx | — | +17 | 17 | New | — |
| D | 2021-08-20 | 2021-08-18 | OSCR | KLEIN JOEL | Chief Policy, Strat. Off | M - OptEx | — | +17 | 17 | New | — |
| D | 2021-08-20 | 2021-08-18 | OSCR | Joyce Meghan V. | COO | M - OptEx | — | +17 | 17 | New | — |
| D | 2021-08-20 | 2021-08-18 | OSCR | Weaver Dennis | Chief Clinical Off | M - OptEx | — | +17 | 17 | New | — |
Purchase Sale Sale after option exercise All abbreviations